PARTNER 3 trial results cap a ten year journey #ACC19 #tavr #PARTNER3

#Sidrabank
3 users can participate in P2P Verification. E.g partner1, partner2 and partner3(partner1 will sent a request to partner2 and 3 to verify him/her while P2 will sent to P1 AND P3 and P3 will sent to P1 and P2.

#AZCoiner_Update

Así es como se ve el catéter de la válvula #Sapien3 de #Edwards con su sistema Flex que permite mejor navegabilidad en anatomías aorticas difíciles.
#TAVI #TAVR #Partner3 #Cardiologia #Cardiology #Intervencionismo #Valve #SomosGIIC

Wow. Just wow. #Partner3 #TAVR first #TAVR #ACCFIT #ACCEARLYCAREER American College of Cardiology #cardiotwitter

Congratulations to the #PARTNER3 investigators for incredible results #ACC19 #Edwards

#PARTNER3 trial - a revolution for #TAVR - #VisualAbstract now live on Visualmed app! Come visit our booth at the #ACC19 #ACCFutureHub to learn more and download the free app to access it: #ACCFIT itunes.apple.com/us/app/visualm…

Nice TOE today in patient with both critical aortic stenosis (AVA 0.45cm2) and mitral valve prolapse resulting in severe regurgitation (P2/3). So, based on recent data should go for TAVI and Mitraclip obviously? 😉 #PARTNER3

Excited for #ACC19 - new primary prevention guidelines, PANACHE trial for #HFpEF , open label extension of PIONEER-HF, PARTNER3 trial for #TAVR , & interesting poster section including T2MI, cardiac rehab and contemporary mgt of LV thrombus, & immune checkpoint inhibitor myocarditis

#ACC19 PARTNER3 AND EVOLUT presented on Day 2- TAVR beats out SAVR in LOW Risk Pts with ~ 46% decrease in Death/stroke/rehosp, SAPIEN 3 superior to surgery and Evolut non-inferior!!
- Truly Historical time TAVR

RT tssmn 'RT JessicaLuc1: This is a very fascinating look at the potential future of #PARTNER3 in low-risk pts - #TAVR and #SAVR having similar short-term outcomes but #TAVR having worse long term survival and higher paravalvular leak. Thank you Dr. … '

After #PARTNER3 sub study findings at #TCT2019 Cardiovascular Research Foundation RTHahnMD Stephen Little, MD Sammy Elmariah MD MPH Madhav Swaminathan Ankitkumar Patel MD MPH FACC FSCAI RPVI Sanford Gips Jae K. Oh Roberto M Lang C. Michael Gibson MD Jordan Strom, MD, MSc, FACC, FASE Dr Roxana Mehran Philippe Pibarot Tiffany Chen

Review of the Partner3 Study Design. #CVSummit ⁦Isaac George MD⁩ Dr George

#PARTNER3 69%👨
nej.md/2CjJ2GU Why so few🙎🏻‍♀️? incorrect Dx of aortic stenosis in older 👵🏻who have⬆️ low-flow, low-gradient severe aortic stenosis,referral bias, anatomical:annular size coronary ostial height & vascular access make current TAVR valves poorly suited to 🙎🏻‍♀️

#PARTNER3 5-y F-Up. Similar outcomes between #TAVR and #SAVR in Low Risk Ptes. #TCT2023

State of art paravalvular leakage after AVR. Precision and perfection of #echofirst diagnostic in the hands of Nicolas Merke 🪄
PVL - not a seldom entity esp. after TAVI Prevalence PVL > moderate after 5J FU - 20,8% (3,2% after SAVR ) - Partner3
AG5-Kardiovaskulärer Ultraschall #dgkKardialeBildgebung

BREAKING! also #PARTNER3 was published before presentation in NEJM - #TAVR in low risk patients (73 years old, STS 1.9%) non-inferior and superior regarding a composite primary endpoint (death, stroke or rehosp at 1 yr)
- long follow up planned!

nejm.org/doi/full/10.10…

#Sidrabank
3 users can participate in P2P Verification. E.g partner1, partner2 and partner3(partner1 will sent a request to partner2 and 3 to verify him/her while P2 will sent to P1 AND P3 and P3 will sent to P1 and P2.

Like ❤ | Repost ♻️ | Comment 💬

#Sidrabank #BTC

Big day for Cardiology and Cardiac Surgery #Partner3 #ACC19

2yr results of #PARTNER3 trial (TAVR w/ Sapien3 valve vs SAVR in low risk pts w/ severe AS) showed:

🔹No sig diff in primary EP of death, stroke or rehosp
🔹More death & stroke in TAVR pts from 1-2 yrs; no sign diff at 2 yrs
🔹Lower CV hospitalizations w/ TAVR

#ACC20 / #WCCardio

#Sidrabank
3 users can participate in P2P Verification. E.g partner1, partner2 and partner3(partner1 will sent a request to partner2 and 3 to verify him/her while P2 will sent to P1 AND P3 and P3 will sent to P1 and P2.